Craig V. Baker, MD
Friedland Professor
Interim Medical Director, Munroe-Meyer Institute
Director, Munroe-Meyer Institute Department of Genetic Medicine
Assistant Professor, UNMC Department of Pediatrics
Biochemical Geneticist
Craig V. Baker, MD, FACMG, is an assistant professor of pediatrics at the University of Nebraska Medical Center and Friedland Professor at UNMC's Munroe-Meyer Institute Department of Genetic Medicine. Baker is a biochemical geneticist and director of MMI's Department of Genetic Medicine as well as the interim medical director of MMI.
Baker, a Nebraska native, joined the MMI genetic medicine team in 2020 as his first faculty position. He is board certified in clinical genetics and medical biochemical genetics. Baker attended medical school in Omaha at Creighton University School of Medicine, completed combined pediatrics-medical genetics residency at the University of Texas Health Science Center of Houston and medical biochemical genetics fellowship at Stanford University.
Baker has a primary clinical interest in patients with inherited metabolic diseases. While clinical care is his primary focus, he has additional interests in teaching and research integrating basic science, genomic data and clinical phenotype.
- Fellowship: Medical Biochemical Genetics, Stanford University, 2020.
- Residency: Pediatrics-Medical Genetics, UTHealth Science Center at Houston, 2019.
- MD: Creighton University School of Medicine, 2015.
- BS: Creighton University, 2011.
- Clinical Genetics and Genomics, board certified 2019.
- Medical Biochemical Genetics, board certified 2021.
Baker provides patient care services at UNMC Munroe-Meyer Institute Department of Genetic Medicine, in specialty clinics across Nebraska and in clinics at Children's Nebraska in Omaha.
Clinic Locations:
- Hillman P, Baker C, Hebert L, et al. Identification of novel candidate risk genes for myelomeningocele within the glucose homeostasis/oxidative stress and folate/one-carbon metabolism networks. Mol Genet Genomic Med. 2020;8(11):e1495. doi:10.1002/mgg3.1495
- Hebert L, Hillman P, Baker C, et al. Burden of rare deleterious variants in WNT signaling genes among 511 myelomeningocele patients. PLoS One. 2020;15(9):e0239083. Published 2020 Sep 24. doi:10.1371/journal.pone.0239083
- Rush ET, Baker CV, Rizzo WB. Dolichol kinase deficiency (DOLK-CDG): Two new cases and expansion of phenotype. Am J Med Genet A. 2017;173(9):2428-2434. doi:10.1002/ajmg.a.38287
- “Biochemical Genetics”, UNMC Human Genetics and Cytogenetics Principles graduate course.
- “Mitochondrial Disorders”, UNMC Genetic Counseling program.
- “The Metabolite is Right”, Stanford Biochemical Genetics Case Conference.
- Biomedical informatics.
- Inherited metabolic disorders.
- Small molecule therapy.
- State newborn screening.
- American College of Medical Genetics.
- American Medical Association.
- National Organization for Rare Disorder, Facilitating Multi-site Research Studies & Clinical Trials Working Group.
- Nebraska Newborn Screening Advisory Committee.
- Society for Inherited Metabolic Disorders.
University of Nebraska Medical Center
Munroe-Meyer Institute
985450 Nebraska Medical Center
Omaha, NE 68198-5450
Explore programs and services available through MMI's Department of Genetic Medicine.